GlassScriptPhysician profile
John Joseph Howell
NPI 1902482607
$2,196.15
in general payments reported to CMS, 2019-2025
14 companies · $893 in 2025
The $893 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $147 · 2023: $617 · 2024: $540 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,049.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $650.17 | 2023-2025 | Axios, General - Interventional Oncology, Embold Fibered |
| Cook Medical LLC | $473.25 | 2023-2025 | Rosch-Uchida, Torcon Nb, Zilver Ptx |
| Kerecis Limited | $381.93 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Penumbra, INC. | $206.09 | 2024-2025 | Indigo System |
| Acera Surgical, INC. | $126.74 | 2022 | |
| Trisalus Life Sciences, INC. | $104.38 | 2024-2025 | Trinav Infusion System |
| Stryker Corporation | $72.62 | 2025 | Artix Mt, Venacore Thrombectomy Catheter |
| Terumo Medical Corporation | $54.13 | 2022-2025 | Angio-Seal |
| Okami Medical, INC. | $33.78 | 2025 | Lobo |
| Veryan Medical Incorporated | $26.84 | 2025 | Biomimics 3d Vascular Stent System |
| Bard Peripheral Vascular, INC. | $17.39 | 2025 | Trek |
| Shockwave Medical, INC | $16.73 | 2025 | |
| W. L. Gore & Associates, INC. | $16.69 | 2025 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion |
| Ethicon US, LLC | $15.41 | 2025 | Dermabond Prineo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.